➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
McKinsey

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

ADAPALENE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Adapalene patents expire, and when can generic versions of Adapalene launch?

Adapalene is a drug marketed by Fougera Pharms, Actavis Mid Atlantic, Aleor Dermaceuticals, Glenmark Generics, P And L, Taro, Tolmar, Call Inc, Glenmark Pharms Ltd, and Perrigo Uk Finco. and is included in fifteen NDAs.

The generic ingredient in ADAPALENE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Drug patent expirations by year for ADAPALENE
Drug Prices for ADAPALENE

See drug prices for ADAPALENE

Drug Sales Revenue Trends for ADAPALENE

See drug sales revenues for ADAPALENE

Recent Clinical Trials for ADAPALENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Aurobindo Pharma LtdPhase 3
Assiut UniversityPhase 4
Foamix Ltd.Phase 2

See all ADAPALENE clinical trials

Pharmacology for ADAPALENE
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for ADAPALENE
Paragraph IV (Patent) Challenges for ADAPALENE
Tradename Dosage Ingredient NDA Submissiondate
DIFFERIN GEL;TOPICAL adapalene 021753 2009-09-15

US Patents and Regulatory Information for ADAPALENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms ADAPALENE adapalene CREAM;TOPICAL 090824-001 Jun 30, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Tolmar ADAPALENE adapalene GEL;TOPICAL 200298-001 Jun 14, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Generics ADAPALENE adapalene GEL;TOPICAL 091314-001 Jul 1, 2010 OTC No No   Start Trial   Start Trial   Start Trial
Perrigo Uk Finco ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 205033-001 Jan 23, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Call Inc ADAPALENE adapalene SOLUTION;TOPICAL 203981-001 Sep 23, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
McKesson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.